SILO PHARMA, INC.
560 Sylvan Ave, Suite 3160
Englewood Cliffs NJ 07632
September 22, 2022
VIA EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Greg Herbers
Re: | Silo Pharma, Inc. | |
Registration Statement on Form S-1 (File No. 333-261532) |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Silo Pharma, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Monday September 26, 2022, or as soon thereafter as practicable.
Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Thank you,
SILO PHARMA, INC.
By: /s/ Eric Weisblum
Name: Eric Weisblum
Title: Chief Executive Officer